Cross-Sector entity
Of the tracked stories, 4 of 4 also mention Boston Scientific, the most common co-covered peer. Across a 7-day span, the pace is roughly 4 stories per week. The busiest single day carried 3. health-it accounts for 1 of the 4 tracked stories, while 3 other categories carry the remainder.
4 verified stories tracked
Last mentioned: Sep 2, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 4 of 4 also mention Boston Scientific, the most common co-covered peer. Across a 7-day span, the pace is roughly 4 stories per week. The busiest single day carried 3. health-it accounts for 1 of the 4 tracked stories, while 3 other categories carry the remainder. The tracked stories average 3.3 original sources each. We currently track 4 Cross-Sector stories that mention West Pharmaceutical Services, published between August 27, 2026 and September 2, 2026.
Computed from the 4 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering West Pharmaceutical Services. Shared-story counts are live from our verified record — not editorial picks.
Public breach disclosure
Novocure publicly reported the cyberattack, disclosing that internal records of more than 1,400 U.S. patients were exposed.
Investigation remains unresolved
SecurityWeek reports no known cybercrime group has claimed responsibility; full scope, nature, and financial impact remain unknown.
No group claims responsibility
SecurityWeek reports no known cybercrime group has taken credit for the attack, and data breach status remains unclear.
Disclosure and market reaction
Company announces global operational disruption, including order processing and shipping systems; shares fall about 4% in morning trading. Evercore ISI estimates a 600-700 bps Q3 revenue impact if recovery mirrors Stryker's three-week timeline.
Public disclosure and stock decline
The company activates incident-response procedures, works with third-party cybersecurity specialists, and files an SEC statement. Shares fall roughly 4% in morning trading.
Cyber incident detected
Boston Scientific detects a cybersecurity incident affecting some IT systems.
Unauthorized access occurs
Novocure says unauthorized access to certain information systems occurred in mid-August 2026, exposing internal patient records.
Incident response activated
Novocure activated its cybersecurity response plan, implemented containment measures, and initiated an internal investigation.
Novocure disclosed a mid-August cyberattack that exposed internal records of more than 1,400 U.S. oncology patients, along with provider contact details and employee job titles. The company said treatment devices were not accessed and that it expects no material financial impact. For healthcare IT and compliance leaders, the incident is another compelling case study in breach response, data classification, and regulatory risk.
Source: CNA
A cybersecurity incident at medical device maker Boston Scientific has disrupted global order processing and shipping systems. Security teams are watching for ransomware involvement and the scope of any data breach as recovery begins. The attack is the latest in a string of healthcare sector cyber incidents.
Boston Scientific's August 25 cyberattack has disrupted global order processing and shipping, creating clinical and financial uncertainty for the medical device maker. Evercore ISI estimates a 600-700 basis point hit to Q3 revenue if recovery follows Stryker's roughly three-week timeline. The company has not yet determined whether the incident will be material.
Source: SecurityWeek
A cybersecurity incident at Boston Scientific has disrupted order processing and shipping globally, threatening hospitals and surgical centers reliant on its devices. Analysts warn of a 600-700 bps Q3 revenue hit if recovery matches Stryker's three-week timeline. Health leaders must assess supply chain and patient care risks.
Source: CNA · Sahil Pandey
